dc.contributor.author | Raje, N | |
dc.contributor.author | Chau, I | |
dc.contributor.author | Hyman, DM | |
dc.contributor.author | Ribrag, V | |
dc.contributor.author | Blay, J-Y | |
dc.contributor.author | Tabernero, J | |
dc.contributor.author | Elez, E | |
dc.contributor.author | Wolf, J | |
dc.contributor.author | Yee, AJ | |
dc.contributor.author | Kaiser, M | |
dc.contributor.author | Landau, H | |
dc.contributor.author | Michot, J-M | |
dc.contributor.author | Hollebecque, A | |
dc.contributor.author | Veronese, L | |
dc.contributor.author | Makrutzki, M | |
dc.contributor.author | Pitcher, B | |
dc.contributor.author | Puzanov, I | |
dc.contributor.author | Baselga, J | |
dc.date.accessioned | 2021-03-04T11:10:42Z | |
dc.date.available | 2021-03-04T11:10:42Z | |
dc.date.issued | 2015-12-03 | |
dc.identifier.citation | JCO precision oncology, 2018, 2 | |
dc.identifier.issn | 2473-4284 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4395 | |
dc.identifier.eissn | 2473-4284 | |
dc.identifier.doi | 10.1200/po.18.00070 | |
dc.format | Electronic-eCollection | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | AMER SOC HEMATOLOGY | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.title | Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2018-01-01 | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1200/po.18.00070 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | JCO precision oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 2 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Myeloma Group | |
dc.contributor.icrauthor | Kaiser, Martin | |